Assumptions were confusing

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.402 (Published 11 February 1995) Cite this as: BMJ 1995;310:402
  1. Pierre Van Damme,
  2. Eddy Van Doorslaer,
  3. Guy Tormans,
  4. Philippe Beutels
  1. Research fellow Professor of health economics Research fellow Research fellow Epidemiology and Community Medicine, University of Antwerp, B-2610 Antwerp, Belgium

    EDITOR,—We have performed economic evaluations of prophylaxis against hepatitis A in travellers, and two of R H Behrens and J A Roberts's main conclusions1 are in line with our findings2 3—namely, that hepatitis A vaccination is not cost saving for the average traveller and that vaccination becomes more cost effective than immunisation with human immunoglobulin when the expected frequency of travel exceeds two occasions in the …

    View Full Text

    Sign in

    Log in through your institution